Fabiana Colelli

发表

The AKT1E17K Allele Promotes Breast Cancer in Mice

P. Zoppoli, G. Viglietto, C. Mignogna, 2022, Cancers.

Novel adamantyl retinoid-related molecules with POLA1 inhibitory activity.

G. Vistoli, L. Musso, S. Dallavalle, 2020, Bioorganic chemistry.

A Herbal Mixture from Propolis, Pomegranate, and Grape Pomace Endowed with Anti-Inflammatory Activity in an In Vivo Rheumatoid Arthritis Model

M. De Leo, C. Pisano, A. Vassallo, 2020, Molecules.

Antitumor activity of novel POLA1-HDAC11 dual inhibitors.

G. Vistoli, L. Musso, S. Dallavalle, 2021, European journal of medicinal chemistry.

AKT1E17K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer

G. Viglietto, C. Mignogna, A. Rizzuto, 2016, PloS one.

GMP-grade nanoparticle targeted to nucleolin downregulates tumor molecular signature, blocking growth and invasion, at low systemic exposure

Rui L. Lopes, Ana C. Gregório, M. Lacerda, 2021 .

Conditional activation of AKT 1 E 17 K promotes breast tumorigenesis in a knockin mouse model ”

G. Viglietto, P. Girolamo, Fabiana Colelli, 2014 .

Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma

I. Sardi, C. Pisano, M. de Martino, 2017, Oncotarget.

The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells

M. Ceccarelli, P. Zoppoli, G. Viglietto, 2015, Oncotarget.

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents

L. Musso, S. Dallavalle, C. Pisano, 2018, PloS one.

Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors.

Erminia Bianchino, L. Musso, S. Dallavalle, 2018, European journal of medicinal chemistry.

The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells

M. Ceccarelli, P. Zoppoli, G. Viglietto, 2015, Oncotarget.